AVITA Medical to Host Investor Webinar Briefing
Key Highlights
- ➤AVITA Medical schedules November 11 investor webinar on third-quarter 2026 results
- ➤Cary Vance and David O’Toole will present and host a Q&A session
- ➤RECELL is FDA-approved for thermal burn and trauma wound treatment
Expert Statements
Cary Vance, President & Chief Executive Officer of AVITA Medical
“The webinar presentation will cover financial and business results from AVITA Medical’s recent third-quarter 2026 earnings webcast and will conclude with a Q&A session.”
VALENCIA, Calif., Nov. 08, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, President & Chief Executive Officer, and David O’Toole, Chief Financial Officer, on Wednesday, November 11, 2026, at 2:00 p.m. Pacific Time (Thursday, November 12, 2026, at 9:00 a.m. Australian Eastern Daylight Time).
The webinar presentation will cover financial and business results from AVITA Medical’s recent third-quarter 2026 earnings webcast and will conclude with a Q&A session. Participants are invited to submit their questions via the registration page.
Get started
Create a free account to read the full story.